p-chloroamphetamine has been researched along with Carcinoma, Hepatocellular in 1 studies
p-Chloroamphetamine: Chlorinated analog of AMPHETAMINE. Potent neurotoxin that causes release and eventually depletion of serotonin in the CNS. It is used as a research tool.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The ability of FPCA to target at hepatoma cells was evaluated and verified with fluorescence confocal observation and flow cytometry analysis." | 1.72 | [Fucoidan-Modified Phase-Transitional Contrast Agent for Ultrasound Imaging and Targeting of Hepatoma Cells]. ( Huang, JB; Peng, YL; Xu, JS; Yan, F; Yang, L; Yang, R, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, JB | 1 |
| Yang, L | 1 |
| Yang, R | 1 |
| Yan, F | 1 |
| Peng, YL | 1 |
| Xu, JS | 1 |
1 other study available for p-chloroamphetamine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
[Fucoidan-Modified Phase-Transitional Contrast Agent for Ultrasound Imaging and Targeting of Hepatoma Cells].
Topics: Carcinoma, Hepatocellular; Contrast Media; Fluorescein-5-isothiocyanate; Humans; Liver Neoplasms; Na | 2022 |